ライフサイエンスコーパス: insulin-like growth factor II

1 ulating expression of growth factors such as insulin-like growth factor II.

2 LD1) pathway that controls the production of insulin-like growth factor II, an autocrine inducer of d

3 more, the cranial nerve 3/4-restricted genes insulin-like growth factor II and guanine deaminase prot

4 ssion of positive growth regulators, such as insulin-like growth factor II and the insulin-like growt

5 utant ES cells are deficient in secretion of insulin-like growth factor II and their defect can be co

6 e VO2peak, REE, and interactions of sex with insulin-like growth factor-II and insulin for whole-body

7 The two contiguous IGF2 (human insulin-like growth factor II) and H19 genes are recipro

8 nt binding protein (CRD-BP), binds to c-myc, insulin-like growth factor II, and beta-actin mRNAs, and

9 centrations of insulin-like growth factor-I, insulin-like growth factor-II, and insulin-like growth f

10 centrations of insulin-like growth factor-I, insulin-like growth factor-II, and insulin-like growth f

11 The data identify insulin-like growth factor II as one developmentally imp

12 growth factor, insulin-like growth factor 1, insulin-like growth factor II, basic fibroblast growth f

13 pendent mannose 6-phosphate receptor and the insulin-like growth factor II/cation-independent mannose

14 annose 6-phosphate receptor (CD-MPR) and the insulin-like growth factor II/cation-independent mannose

15 s, the cation-dependent MPR (CD-MPR) and the insulin-like growth factor II/cation-independent MPR, ca

16 t growth factor, and nerve growth factor and insulin-like growth factor II, either alone or in variou

17 We present evidence that SYT-SSX1 induces insulin-like growth factor II expression in fibroblast c

18 analysis of loss of imprinting (LOI) of the insulin-like growth factor II gene (IGF2) in tumours.

19 Loss of genomic imprinting (LOI) of insulin-like growth factor II gene (IGF2) involves abnor

20 Loss of imprinting (LOI) of the insulin-like growth factor II gene (IGF2) is an epigenet

21 Human insulin-like growth factor II gene (IGF2) is overexpress

22 The insulin-like growth factor II gene (Igf2) is paternally

23 LOI), an epigenetic alteration affecting the insulin-like growth factor II gene (IGF2), is found in n

24 use model of loss of imprinting (LOI) of the insulin-like growth factor II gene (Igf2), which shows a

25 The human insulin-like growth factor II gene is regulated in a dev

26 Loss of imprinting of insulin-like growth factor-II gene (IGF2) and/or loss of

27 Loss of imprinting (LOI) of the insulin-like growth factor-II gene (IGF2), leading to ab

28 ve described loss of imprinting (LOI) of the insulin-like growth factor-II gene (IGF2), leading to bi

29 ylation, and loss of imprinting (LOI) of the insulin-like growth factor-II gene (IGF2).

30 We observed LOI of the insulin-like growth factor-II gene in twelve of twenty-s

31 The insulin-like growth factor-II gene lies within the 11p15

32 macroglobulin, growth hormone receptors, and insulin-like growth factor II genes.

33 rest identified differential localization of insulin-like growth factor II, guanine deaminase, periph

34 loci and the genes coding for p53, p57, and insulin-like growth factor II, have been reported in adr

35 differentiation medium and are defective in insulin like growth factor-II (IGF-II) secretion, an aut

36 -6, tumor necrosis factor alpha (TNF-alpha), insulin-like growth factor II (IGF II), and parathyroid

37 sing alpha ML cells is strongly inhibited by insulin-like growth factor II (IGF II).

38 etal bovine serum and carries mature 7.5-kDa insulin-like growth factor II (IGF-II) and at least 12 d

39 N-myc2 and insulin-like growth factor II (IGF-II) are coordinately

40 de (ANP), relaxin, glucagon, proinsulin, and insulin-like growth factor II (IGF-II) bind to and are d

41 The insulin-like growth factor II (IGF-II) gene is located w

42 The insulin-like growth factor II (IGF-II) gene is maternall

43 ancer (insulinoma) cells that do not produce insulin-like growth factor II (IGF-II) grow slowly in pu

44 studies showed that a bilateral injection of insulin-like growth factor II (IGF-II) into the dorsal h

45 Insulin-like growth factor II (IGF-II) is a major embryo

46 Insulin-like growth factor II (IGF-II) mRNA-binding prot

47 CRD-BP is also known as insulin-like growth factor II (IGF-II) mRNA-binding prot

48 IMP3, a member of a family of insulin-like growth factor II (IGF-II) mRNA-binding prot

49 In this study, the short-term effects of insulin-like growth factor II (IGF-II) on extraocular mu

50 with IL-3 alone or with both IL-3 and either insulin-like growth factor II (IGF-II) or stem cell grow

51 Since insulin-like growth factor II (IGF-II) receptors facilit

52 a systemic administration of the polypeptide insulin-like growth factor II (IGF-II) reverses all thes

53 st the effects of systemic administration of insulin-like growth factor II (IGF-II), a polypeptide th

54 six imprinted genes within this domain: (a) insulin-like growth factor II (IGF-II), an important aut

55 rising insulin-like growth factor I (IGF-I), insulin-like growth factor II (IGF-II), and their bindin

56 ression of another known PLAGL2 target gene, insulin-like growth factor II (IGF-II), was greatly dimi

57 depends on the interaction of a fragment of insulin-like growth factor II (IGF-II), with the IGF-II

58 ut in mammals the latter also interacts with insulin-like growth factor II (IGF-II).

59 owth factors, the most prevalent of which is insulin-like growth factor II (IGF-II).

60 cell lines lacking endogenous expression of insulin-like growth factor II (IGF-II).

61 l lines that lacked endogenous expression of insulin-like growth factor II (IGF-II).

62 ate (Man-6-P)-containing acid hydrolases and insulin-like growth factor II (IGF-II).

63 The M6P/IGF2R gene, encoding the insulin-like growth factor II (IGF-II)/mannose 6-phospha

64 The insulin-like growth factor II (IGF-II)/mannose 6-phospha

65 We report that, in the rat, administering insulin-like growth factor II (IGF-II, also known as IGF

66 Recent studies indicate that insulin-like growth factor-II (IGF-II) acts as an autocr

67 However, the up-regulation of insulin-like growth factor-II (IGF-II) expression is a p

68 The physiological role of circulating insulin-like growth factor-II (IGF-II) in adult humans i

69 Insulin-like growth factor-II (IGF-II) is an embryonic g

70 n-regulated in prostate cancer, up-regulates insulin-like growth factor-II (IGF-II) mRNA and protein

71 IMP-3, a member of the insulin-like growth factor-II (IGF-II) mRNA-binding prot

72 The insulin-like growth factor-II (IGF-II) receptor (IGF2R)

73 Mannose-6-phosphate (M6P)/insulin-like growth factor-II (IGF-II) receptor is a mul

74 ll as a possible target of let-7 regulation, insulin-like growth factor-II (IGF-II).

75 tors (augmenter of liver regeneration [ALR], insulin-like growth factor-II [IGF-II], and hepatocyte g

76 imprinted genes; these include the gene for insulin-like growth factor II (IGF2) and H19, which show

77 Extensive methylation of insulin-like growth factor II (IGF2) and hypermethylated

78 Using allelic regulation of mouse insulin-like growth factor II (Igf2) as a model, we demo

79 Insulin-like growth factor II (IGF2) belongs to a family

80 med comparative evolutionary analyses of the insulin-like growth factor II (IGF2) gene in teleost fis

81 thesize that loss of imprinting (LOI) of the insulin-like growth factor II (IGF2) gene is associated

82 The insulin-like growth factor II (IGF2) gene is paternally

83 demethylation of repeated sequences, loss of insulin-like growth factor II (IGF2) imprinting, abrogat

84 Loss of genomic imprinting of insulin-like growth factor II (IGF2) is a hallmark of ma

85 Insulin-like growth factor II (Igf2) is maternally impri

86 The gene for insulin-like growth factor II (IGF2) is normally express

87 ted diet during E11-17 have higher levels of insulin-like growth factor II (IGF2) mRNA and protein in

88 In mammalian embryos, the expression of Insulin-like growth factor II (IGF2) plays a key role in

89 eptors (M6P/IGF2R) bind and target exogenous insulin-like growth factor II (IGF2) to the prelysosomes

90 has been particularly true for the imprinted Insulin-like Growth Factor II (IGF2), a key regulator of

91 singly, LOI of LIT1 was not linked to LOI of insulin-like growth factor II (IGF2), which was found in

92 s of this process for the imprinted gene for insulin-like growth factor II (IGF2).

93 f the normally silent maternal allele of the insulin-like growth factor-II (IGF2) gene, silencing of

94 R1; myoblast determination protein 1, MYOD1; insulin-like growth factor II, IGF2; tumor suppressor ca

95 High levels of insulin-like growth factor II (IGFII) mRNA expression ar

96 , IMP-3 binds to and promotes translation of insulin-like growth factor II (IGFII) mRNA.

97 otein of recombinant NAGLU and a fragment of insulin-like growth factor II (IGFII) was prepared for e

98 2 myoblasts by controlling the expression of insulin-like growth factor-II in a kinase-independent ma

99 Vesamicol did not have any effect on EGF or insulin-like growth factor-II-induced growth of human BA

100 n of the insulin-like growth factor I and/or insulin-like growth factor II levels or secretion.

101 rocess of characterizing mannose 6-phosphate/insulin-like growth factor II (M-6-P/IGF-II) receptor bi

102 ytoplasmic domain of the mannose 6-phosphate/insulin-like growth factor-II (Man-6-P/IGF-II) receptor.

103 in-regulatable aminopeptidase, receptors for insulin-like growth factor-II/Man-6-phosphate and transf

104 The insulin-like growth factor II/mannose 6-phosphate recept

105 A soluble form of the insulin-like growth factor II/mannose 6-phosphate recept

106 The insulin-like growth factor II/mannose 6-phosphate recept

107 erminants of carbohydrate recognition by the insulin-like growth factor II/mannose 6-phosphate recept

108 6-phosphate (Man-6-P) binding domains of the insulin-like growth factor II/mannose 6-phosphate recept

109 The insulin-like growth factor II/mannose 6-phosphate recept

110 lated and nonbiotinylated populations of the insulin-like growth factor-II/mannose 6-phosphate recept

111 e 6-phosphate (Man-6-P) binding sites of the insulin-like growth factor-II/mannose 6-phosphate recept

112 oluble forms of the human cation-independent insulin-like growth factor-II/mannose 6-phosphate recept

113 The insulin-like growth factor-II/mannose 6-phosphate recept

114 distinct cell surface recycling pathways for insulin-like growth factor-II/mannose 6-phosphate recept

115 ), the cation-dependent MPR (CD-MPR) and the insulin-like growth factor II/MPR (IGF-II/MPR), recogniz

116 However, high levels of insulin-like growth factor II mRNA are detected in many

117 d Igf2bp1, a VICKZ (Vg1 RNA binding protein, Insulin-like growth factor II mRNA binding protein 1, Co

118 Endogenous insulin-like growth factor II mRNA derived from the P3 a

119 H19 RNA and insulin-like growth factor II mRNA were up-regulated sig

120 specific binding sites were detected in the insulin-like growth factor II P3 promoter.

121 The insulin/insulin-like growth factor (IIS) pathway comprises a sin

122 ding latent transforming growth factor-beta, insulin-like growth factor-II, plasminogen, and urokinas

123 nic effects of insulin-like growth factor I, insulin-like growth factor II, platelet-derived growth f

124 so identified several growth factors such as insulin-like growth factor-II, platelet-derived growth f

125 shing mTOR activity, which in turn decreased insulin-like growth factor II production and autocrine s

126 levels of transcription of an Sp1-dependent insulin-like growth factor II promoter construct in MCF-

127 Insulin-like growth factor II receptor (IGF2R) is a mult

128 antagomir-352 up-regulated the expression of insulin-like growth factor II receptor (IGF2R), which ma

129 The insulin-like growth factor II receptor (IGFIIR) gene has

130 The insulin-like growth factor II receptor (IGFIIR) has been

131 The cation-independent mannose 6-phosphate/insulin-like growth factor II receptor (M6P/IGF-II recep

132 EG binds directly to the mannose-6-phosphate/insulin-like growth factor II receptor (M6P/IGF2R) depen

133 The mannose 6-phosphate/insulin-like growth factor II receptor (M6P/IGF2R) forms

134 f lysosomal enzymes, the mannose 6-phosphate/insulin-like growth factor II receptor (M6P/IGF2R) plays

135 Mannose 6-phosphate/insulin-like growth factor II receptor (M6P/IGF2R) tumor

136 c acid (RA) binds to the mannose-6-phosphate/insulin-like growth factor II receptor (M6P/IGF2R) with

137 , we have identified the mannose 6-phosphate/insulin-like growth factor II receptor (M6P/IGFIIR) as a

138 n the trafficking of the mannose 6-phosphate/insulin-like growth factor II receptor (Man-6-P/IGF-II r

139 or (uPAR) binding by the mannose 6-phosphate/insulin-like growth factor II receptor (Man-6-P/IGF2R) i

140 of chemotherapy; (c) the mannose 6-phosphate/insulin-like growth factor II receptor and the TGF-beta

141 ated by isolation of the mannose 6-phosphate/insulin-like growth factor II receptor and the transform

142 urine cation-independent mannose 6-phosphate/insulin-like growth factor II receptor cytoplasmic domai

143 ted short tandem repeat polymorphisms of the insulin-like growth factor II receptor gene (IGF2R) in o

144 in their coding sequences, such as BAX, the insulin-like growth factor II receptor IGFIIR, and even

145 a possible role for the mannose 6-phosphate/insulin-like growth factor II receptor in GUS transport

146 zation of TGF-beta1, the mannose 6-phosphate/insulin-like growth factor II receptor, the TGF-beta typ

147 life is mediated by the mannose 6-phosphate/insulin-like growth factor II receptor.

148 y the induction by KSHV of the expression of insulin-like growth factor-II receptor (IGF-IIR), a mann

149 The mannose 6-phosphate/insulin-like growth factor-II receptor (M6P/IGFIIR) play

150 Cell surface mannose 6-phosphate/insulin-like growth factor II receptors (M6P/IGF2R) bind

151 nalytes (leptin, prolactin, osteopontin, and insulin-like growth factor-II), that can discriminate be

152 r, is particularly striking and includes the insulin-like growth factor II, the cisplatin resistance-

153 ting (GILT) tag, which contains a portion of insulin-like growth factor II, to create an active, chim

154 of the nutrient- and stress-sensing insulin/insulin-like growth factor (IIS)/TOR signalling network,

155 Autocrine gastrins, insulin-like growth factor-II, transforming growth facto

156 trations of insulin-like growth factor-I and insulin-like growth factor-II were low and remained low

157 This autoantigen binds to mRNA encoding insulin-like growth factor II, which has been found to b